Home | Opella
On October 21st, Sanofi announced it has entered into exclusive negotiations with CD&R to sell a controlling stake in Opella. This announcement is a major and exciting milestone on our journey to becoming a leading fast-moving consumer healthcare player globally.
Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes
Oct 30, 2024 · Sanofi announced that it has entered into exclusive negotiations with the US private equity firm Clayton, Dubilier & Rice (CD&R) to transfer around 50% controlling stake in Opella.
Our Brands - Opella
Learn about Opella's brands such as Buscopan, Icy Hot, and Dulcolax that are helping more people champion better self-care.
About us - Opella
Learn about Opella's commitment to make health better by empowering people to champion self-care. Discover our actions and our values today.
Sanofi in exclusive talks with CD&R over sale of $17 billion Opella
Oct 21, 2024 · French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice...
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
3 days ago · Opella employs more than 11,000 people worldwide and is known for making Doliprane, one of France’s most-sold paracetamol-based painkillers. The medicine is so popular that most paracetamol products are referred to as Doliprane, regardless of the manufacturer. In addition, Opella develops allergy treatment Allegra (fexofenadine) and irritable ...
Sanofi and CD&R sign Opella share purchase agreement
3 days ago · Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the share purchase agreement in relation to the sale of a 50% controlling stake in Opella to CD&R. Bpifrance is expected to participate as a minority shareholder with a c.2% stake in Opella, with Sanofi remaining a significant shareholder.
Oct 21, 2024 · Opella with Sanofi to remain a significant shareholder • With 11,000 talented and passionate people bringing iconic brands to life, Opella poised to ignite new bold development journey
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions …
Oct 21, 2005 · Partnering with CD&R will allow Opella to unlock its full development potential, to further drive value creation and deploy the exceptional talent of our teams to become a leading company in the fast-moving consumer healthcare space.
Press Release: Sanofi and CD&R sign Opella share purchase
3 days ago · Sanofi and CD&R sign Opella share purchase agreement. Paris, February 19, 2025.Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed ...